Medicinal product name Rolufta Ellipta
Pharmaceutical form Inhalation powder, pre-dispensed
Strength 55 µg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code R03BB07 Drugs for obstructive airway diseases

Important notice

Additional information regarding the use for persons aged 75+

If used as "DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES"
SubstanceClassComment
Umeclidinii bromidumASuitable for older persons. Anticholinergic. Take into account possible systemic adverse effects

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(55 µg/dose)
Inhaler    EU/1/17/1174/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/17/1174/002
Date of authorisation Mar 20, 2017
Marketing authorisation holder, country GlaxoSmithKline Trading Services Limited, Ireland